Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
47 Leser
Artikel bewerten:
(0)

RaySafe Highlights Real-Time Radiation Dose Monitoring System at CIRSE 2015

RaySafe i2 Dosimeter to be demonstrated at the CIRSE Radiation Protection Pavilion

EVERETT, Washington, Sept. 28, 2015 /PRNewswire/ --Unfors RaySafe Inc., a Fluke Biomedical company and the leading manufacturer of real-time dose monitoring solutions for high-dose labs, will educate interventional radiologists about measuring and reducing their own radiation dose at the 30th annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) September 26-30 in Libson, Portugal.

Logo- http://photos.prnewswire.com/prnh/20150304/179432LOGO

CIRSE attendees will learn the significant benefits the RaySafe i2 can offer interventional radiologists, electrophysiologists, interventional cardiologists and other clinical staff for reducing radiation dose, Excess radiation has been connected with the development of harmful medical conditions such as cataracts and even brain tumors. The RaySafe i2 active dosimetry system gives real-time insight about personal radiation exposure, allowing medical staff to change their behavior in order to minimize their exposure.

"Based on my own experiences in working with ionizing radiation throughout my career, I feel that it is critical that physicians, nurses but alsohospital administrators understand the serious health consequences that can and do result from long-term exposure to radiation," said Professor Böckler,University Hospital Heidelberg, Department of Vascular and Endovascular Surgery. "European healthcare facilities are pioneersfor protection against the troubling health consequences that come with excessive radiation exposure and have looked for ways that can guard against this type of exposure and heighten awareness through advanced technologies such as the RaySafe i2."

RaySafe Dose Hero
New this year, all CIRSE attendees will have the opportunity to play the RaySafe Dose Hero. RaySafe has created a quick, interactive game controlled by Xbox-Kinect to test the ability of CIRSE attendees to virtually help a surgeon while avoiding exposure to excessive radiation. In the first round, the player will have to collect tools and hand them to the surgeon during a procedure, thereby moving around the room and encountering radiation at various points. During the second round, the player receives his/her real-time dose feedback from the RaySafe i2, educating them on how much exposure he/she received during the single procedure.

"There is lack of awareness about unnecessary radiation exposure for medical staff in hospitals and clinics. We have implemented the RaySafe Dose Hero so attendees can see their own results of real-time dose feedback from the RaySafe i2," stated Bart LeClou, Director Business Area "Personal Dosimetry" at Unfors RaySafe. "The i2 system gives immediate feedback so corrective action can be taken to help protect every individual in the operating room. Physicians and their clinical teams need advocates to help make cath labs safe in the hospitals and across the world, and we are here to support them."

To learn more about radiation dose safety and real-time dose monitoring, visit the RaySafe booth # RPP4 during CIRSE. Professor Bockler will also be in attendance to discuss both his experiences and insights as it pertains to radiation safety for staff.

About Fluke Biomedical
Trusted for the measurements that matter.
Fluke Biomedical is the premier, global provider of test and measurement equipment and services to the healthcare industry. We serve biomedical engineers, quality-assurance technicians, medical physicists, oncologists and radiation-safety professionals and are continually expanding our range of solutions to a broader range of health and safety professionals. For more information, visit www.flukebiomedical.com.

About Unfors RaySafe, Inc.
Unfors RaySafe, a Fluke Biomedical company, is the leading manufacturer of instruments for the quality assurance and service of diagnostic x-ray equipment and real-time dose monitoring solutions for high-dose labs. Thousands of satisfied medical physicists, service engineers, biomedical engineers, government inspectors and major manufacturers of quality X-ray machines throughout the world use RaySafe products today. For additional information, visit www.raysafe.com and follow us on Facebook and @Unfors_RaySafe.

For more information:
Marissa Confredo
KNB Communications
203-504-8230 ext.135
mconfredo@knbcomm.com

© 2015 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.